Great to have Steve Greene all the way from Duke Clinical Research Institute here in Adelaide CSANZ reminding us of the importance of simultaneous commencement & rapid titration of HFrEF therapies. Incredible body of work highlighting gaps and importantly a path forward! Carolyn Lam